DCSZ11

DRUG2 trials

Sponsors

DynamiCure Biotechnology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Advanced or Metastatic Solid TumorsRectal Cancer

Phase 1

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

RecruitingNCT05785754

DynamiCure BiotechnologyAdvanced or Metastatic Solid Tumors

Start: 2023-06-28End: 2026-12-31Target: 320Updated: 2025-06-26

Phase 2

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Not yet recruitingNCT07580339

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsRectal Cancer

Start: 2026-07-01End: 2030-07-01Target: 30Updated: 2026-05-12